Advances in the Early Detection of Hepatobiliary Cancers
Hepatocellular cancer (HCC) and biliary tract cancers (BTCs) have poor survival rates and a low likelihood of a cure, especially in advanced-stage disease. Early diagnosis is crucial and can significantly improve survival rates through curative treatment approaches. Current guidelines recommend abdo...
Main Authors: | Hasan Çağrı Yıldırım, Gozde Kavgaci, Elvin Chalabiyev, Omer Dizdar |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/15/3880 |
Similar Items
-
Advances in Targeted Immunotherapy for Hepatobiliary Cancers
by: Samantha M. Ruff, et al.
Published: (2022-11-01) -
Advances in medical treatment of advanced hepatobiliary and pancreatic cancer in 2022
by: Le Zhang, et al.
Published: (2023-02-01) -
Biomarkers in Hepatobiliary Cancers: What Is Useful in Clinical Practice?
by: Alice Boilève, et al.
Published: (2021-05-01) -
Changing Epidemiological Trends of Hepatobiliary Carcinomas in Austria 2010–2018
by: Florian Hucke, et al.
Published: (2022-06-01) -
Sarcopenia increases the risk of early biliary infection after percutaneous transhepatic biliary stent placement
by: Qi Chen, et al.
Published: (2022-12-01)